Summary

eGenesis Bio

Founded in 2015

Description

We strive to make xenotransplantation a routine medical procedure for the delivery of safe & effective human transplantable cells, tissues & organs.

Strengths

  • eGenesis Bio has a strong market share in their industry
  • Revenue generated per employee is greater than industry average
  • Revenue growth is more steady than the industry average
  • Since eGenesis Bio was founded, the company has grown faster than the industry average
  • Web traffic rankings are better than the industry average

Weaknesses

  • Revenue growth is less than the industry average
  • The number of employees is not growing as fast as the industry average

Annual Revenue

eGenesis Bio's annual revenue

$12681000

Based on Kona Equity data

  • Revenue per employee

    $211000

  • Variance of revenue growth

    0.07

  • Annual revenue growth since founding

    $1811571

  • Revenue growth rate from first known quarter to current

    13.2%

Employee Count

60 employees

  • Employee growth rate from first known quarter to current

    7.1%

Executives

Kenneth Fan

Chief Operating Officer

k**@egenesisbio.com

G Score - 5

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G2 Income per employee more than industry average.
  • G5 Variance of revenue growth is less than the industry average
  • G6 Annual revenue growth since founding is higher than the industry average.
  • G7 Website traffic rankings are better than the industry average

Web Analysis

  • Rank

    2.34 M

  • Page views per visitor

    1.0

  • Daily time

    2:25

Location

300 Technology Sq., Ste. 301 
Cambridge, MA  2139

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Key Information

  • Name: eGenesis Bio
  • Category: Biotechnology
  • Industry: Pharmaceutical Company
  • SIC: 87; 873
  • NAICS: 5417; 541
  • Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with eGenesis Bio.

    See similar companies

    Next step

    Visitors review